AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.

The AHA recommended whole exome or whole genome sequencing as first-line diagnostic tools for mitochondrial diseases.

A free two-day event in Cambridge will unite experts to discuss translational advances in cell and gene therapy, spanning rare diseases, cancer immunotherapy, and genome editing.

Codon develops curated PR solutions for transformational biotech companies at every stage to help establish brand credibility, raise awareness of their pioneering products, elevate their reputation as ...

Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that data on its lead antibacterial ...

The Indian Constitution embodies the principles of equitable development, democracy, pluralism, secularism and principles of natural justice, for which the country stands for. Indians today are proud ...

In the early days of Russia’s war in Ukraine, volunteers and charitable foundations began assembling small-scale drones to ...

Silicon Valley is home to some of the most powerful investors in the nation. Check out this list of some of the most well-known investors in the Valley.

Fledgling universities funded by kings and other leaders hired professors for their chemistry departments. Organic chemistry became a recognized discipline. These developments established an entirely ...

ELRIG has revealed Drs Stephen Ward (Cell and Gene Therapy Catapult) and Annarita Miccio (Imagine Institute) as keynote ...

A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act like molecular anchors. The work confirms these tags actively silence genes, ...

Aurora Therapeutics' first target is the rare inherited disease phenylketonuria, also known as PKU. Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013 ...